Synkromax Biotech Private Limited, a active private limited company, was established on 11 August 2009 in Thirumazhisai, Tamil Nadu, India. Engaging in agri support services within the manufacturing sector, it holds CIN: U74999TN2009PTC072537. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹10.78 Cr.
Formerly known as Shri Meera Biotech Private Limited. It upholds a compliant status. Employing 44 professional, Its leadership includes Usha Subramanian (Director), Subramanian Veluchamy (Managing Director). Past directors included Seshadri, Soma Guhathakurta, Arvind Kumar Chandak. It holds ₹46.88 Cr open charges and ₹19.73 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Module No.26 To 31, Ii Floor Sidco Multistoryed Complex, Sidco Indust, Rial Estat, Thirumazhisai, Tamil Nadu, 600124.
U74999TN2009PTC072537
072537
11 August 2009
₹25.00 Cr
₹10.78 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Synkromax Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Usha Subramanian | Director | 20 Jul 2020 | Current |
| Subramanian Veluchamy | Managing Director | 09 May 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 14 Jun 2020 | Past |
| Pramod Abcsdd | Director | 13 Jul 2018 | Past |
| Pramod Abcsdd | Director | 22 Oct 2018 | Past |
| Pramod Abcsdd | Director | 15 Nov 2011 | Past |
| Pramod Abcsdd | Director | 15 Nov 2011 | Past |
| Pramod Abcsdd | Director | 26 Aug 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synkromax Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.55% increase. The company also saw a substantial fall in profitability, with a 73.18% decrease in profit. The company's net worth Soared by an impressive increase of 36.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Synkromax Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹468,800,000.00
₹197,262,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Nov 2024 | Indian Overseas Bank | ₹46.85 Cr | Open |
| 23 Jan 2024 | Others | ₹0.30 M | Open |
| 12 Jan 2023 | Bank Of India | ₹1.18 Cr | Satisfied |
| 06 Aug 2021 | Sidbi | ₹1.44 Cr | Satisfied |
| 30 Mar 2021 | Bank Of India | ₹1.41 Cr | Satisfied |
Explore comprehensive loan charge details -
Synkromax Biotech has a workforce of 44 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Synkromax Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synkromax Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Indian Overseas Bank of Rs. 46.85 Cr registered on 15 Nov 2024 with Charge ID 101003461 was modified on 02 Dec 2024. was completed.
A charge registered on 12 Jan 2023 via Charge ID 100679370 with Bank Of India was fully satisfied on 28 Nov 2024. was recorded as a recent event.
Progress on A charge registered on 30 Mar 2021 via Charge ID 100447414 with Bank Of India was fully satisfied on 28 Nov 2024. was documented.
Progress on A charge registered on 27 Mar 2020 via Charge ID 100335711 with Bank Of India was fully satisfied on 28 Nov 2024. was documented.
The activity A charge registered on 09 Jan 2012 via Charge ID 10333712 with Bank Of India was fully satisfied on 28 Nov 2024. was completed.
Progress on A charge with Indian Overseas Bank amounted to Rs. 46.85 Cr with Charge ID 101003461 was registered on 15 Nov 2024. was documented.
The CIN of Synkromax Biotech Private Limited is U74999TN2009PTC072537.
Synkromax Biotech Private Limited is headquartered at Module No.26 To 31, Ii Floor Sidco Multistoryed Complex, Sidco Indust, Rial Estat, Thirumazhisai, Tamil Nadu, 600124.
Synkromax Biotech Private Limited was incorporated on 11 August 2009.
The current directors of Synkromax Biotech Private Limited are
The primary industry of Synkromax Biotech Private Limited is Manufacturing.
Synkromax Biotech Private Limited is unlisted.
The authorized capital of Synkromax Biotech Private Limited is ₹25.00 Cr, and the paid-up capital is ₹10.78 Cr.
The compliance status of Synkromax Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX